New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
09:38 EDTTEVA, AAPL, BIDU, FDX, TSLA, TWTRActive equity options trading on open
Active equity options trading on open according to Track Data: TWTR BIDU AAPL FDX TSLA TEVA
News For TEVA;AAPL;BIDU;FDX;TSLA;TWTR From The Last 14 Days
Check below for free stories on TEVA;AAPL;BIDU;FDX;TSLA;TWTR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
August 7, 2014
13:55 EDTTEVATeva won't be meaningfully hurt soon by new Copaxone filing, says BMO Capital
After Teva (TEVA) confirmed that it received the first paragraph IV notice for the 3x per week version of its Copaxone drug from Dr. Reddy's (RDY), BMO Capital said it had expected companies to seek to market a generic version of the latest Copaxone formulation, but was surprised that Dr. Reddy's took this action. The firm notes that Teva's decision to file a lawsuit against Dr. Reddy over the application will trigger a 30 month stay of approval of the generic version,. BMIO Capital says that investors should keep this issue on their radar, but the firm does not expect Teva to be meaningfully hurt in the near-term by this development. It keeps an Outperform rating on Teva.
12:06 EDTTEVATeva will continue to defend COPAXONE intellectual property rights
Teva (TEVA) confirmed that it has received the first paragraph IV notice for its three-times-a-week COPAXONE 40 mg/mL product from Dr. Reddy’s Laboratories (RDY). Teva will continue to vigorously defend its COPAXONE intellectual property rights against infringement wherever they are challenged. Teva intends to file a lawsuit for patent infringement against Dr. Reddy’s within the 45 day period provided under the Hatch-Waxman Act. The filing of the lawsuit will trigger a 30 month stay of FDA approval of Dr. Reddy’s ANDA. COPAXONE 40 mg/mL is protected by two Orange Book patents that expire in 2030.
10:20 EDTTEVAMylan says litigation ins ongoing in India regarding Teva
Mylan (MYL) said that it expects Teva's (TEVA) efforts to seek an injunction will "as ineffective as it was in U.S. courts." The company said it will not provide further comment on the matter. Mylan said it will also postpone its 2014 Investor Day due to the ongoing nature of the Abbott (ABT) transaction. It expects its fully realized savings and profit from new products will not be realized till 2015. Comments taken from Q2 earnings conference call.
09:36 EDTAAPL, TSLAActive equity options trading on open
Subscribe for More Information
06:43 EDTAAPLApple poaches YSL's Catherine Monier, 9to5Mac reports
Subscribe for More Information
06:19 EDTAAPLMicrosoft in talks to open Fifth Avenue store, Daily News reports
Subscribe for More Information
06:17 EDTFDXFedEx added to Focus List at Citigroup
Subscribe for More Information
06:07 EDTTSLATesla implied volatility of 40 at lower end of index mean range
Subscribe for More Information
August 6, 2014
16:01 EDTTSLA, AAPL, TWTROptions Update; August 7, 2014
Subscribe for More Information
13:57 EDTTSLATesla appoints Robyn Denholm as first woman on its board
Tesla (TSLA) announced that Robyn Denholm has been appointed to its board, effective August 11. Denholm has also been appointed to chair the company’s audit committee and be a member of the compensation and nominating and corporate governance committees. These roles were previously filled by Brad Buss, who is vacating his committee positions upon joining SolarCity (SCTY) as its CFO. Buss will remain a member of Tesla’s board. Denholm joined Juniper Networks (JNPR) in 2007 and currently serves as its executive VP, CFO, and COO.
12:31 EDTTSLATesla rallies after analyst starts coverage with $316 price target
Subscribe for More Information
11:06 EDTTSLATesla spikes higher, levels to watch
Shares were last up 3.4% to $246.71. At that price next resistance is at $247.88, the session high, and then at $250.56. Support is at $244.81.
10:43 EDTTSLATesla shares rise, levels to watch
Subscribe for More Information
10:18 EDTTWTRTwitter drifts lower, levels to watch
Subscribe for More Information
10:00 EDTTSLAOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Burlington Stores (BURL) initiated with a Neutral at Sterne Agee... EZchip (EZCH) initiated with an Outperform at Imperial Capital... FIS (FIS) initiated with a Buy at Monness Crespi... Fiserv (FISV) initiated with a Buy at Monness Crespi... Michaels Stores (MIK) initiated with a Buy at Deutsche Bank... Nordson (NDSN) initiated with a Market Perform at Wells Fargo... PepsiCo (PEP) initiated with a Reduce at Nomura... Restoration Hardware (RH) coverage assumed with an Outperform at Avondale... RingCentral (RNG) initiated with an Outperform at Oppenheimer... ServiceMaster (SERV) initiated with a Buy at BofA/Merrill... Tesla (TSLA) initiated with an Outperform at Pacific Crest... Under Armour (UA) initiated with a Fair Value at CRT Capital.
09:36 EDTTWTR, TSLA, AAPLActive equity options trading on open
Subscribe for More Information
08:44 EDTAAPLApple products excluded from Chinese government procurement list, Bloomberg says
Subscribe for More Information
06:43 EDTTSLATesla finds solution for China trademark disagreement, Reuters says
Tesla Motors said it has "completely and amicably" found a solution to a trademark dispute against Chinese businessman Zhan Baosheng, getting rid of an obstacle that had foreshadowed CEO Elon Musk's target to broaden quickly in the globe's largest car market, according to Reuters, citing an e-mailed statement from the U.S. electric vehicle manufacturer. Reference Link
06:09 EDTAAPLApple, Samsung to drop all litigation outside U.S., Re/code reports
Subscribe for More Information
05:47 EDTTSLATesla initiated with an Outperform at Pacific Crest
Pacific Crest started shares of Tesla Motors (TSLA) with an Outperform rating saying the premium investors are willing to pay for the stock is likely to go higher due to healthy demand trends, achievable near-term targets and an underappreciated growth trajectory into 2016. The firm set a $316 price target for Tesla shares, which closed yesterday down 3c to $238.49.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use